Zurueck zur Suche

Reporte zur Charge U031561

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OH 2 IL 2 PA 1 WI 1 MI 1

VAERS 2633569

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031561

gering
Staat
OH
Alter
2,0
Geschlecht
F
Eingang
18.05.2023
Impfdatum
11.05.2023
Beginn
01.05.2023
Tage bis Beginn
-
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

none

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2633567

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031561

gering
Staat
OH
Alter
4,0
Geschlecht
M
Eingang
18.05.2023
Impfdatum
11.05.2023
Beginn
01.05.2023
Tage bis Beginn
-
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event

Symptomtext

There was not an adverse reaction

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
Ibuprofen
Vorherige Impfungen
-

VAERS 2517539

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031561

gering
Staat
PA
Alter
1,0
Geschlecht
U
Eingang
28.11.2022
Impfdatum
04.11.2022
Beginn
04.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Overdose

Symptomtext

Caller reported VARIVAX and PROQUAD were administered to a 12 month old at the same visit. No other information provided. No Additional AEs or PQC reported.; Caller reported VARIVAX and PROQUAD were administered to a 12 month old at the same visit. No other information provided. No Additional AEs or PQC reported.; This spontaneous report was received from a nurse prescriber and refers to a 12-month-old patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 04-NOV-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant Human albumin (rHA) (PROQUAD) 0.5 milliliter (ml), lot # U031561, expiration date: 06-APR-2023, administered subcutaneously (SQ) for prophylaxis (strength was not provided), and varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml, lot # U015681, expiration date: 18-MAY-2023, administered subcutaneously for prophylaxis (strength was not provided) (Overdose) at the same visit. No other adverse event occurred (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2415557

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031561

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
19.08.2022
Impfdatum
03.08.2022
Beginn
03.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

No symptoms or adverse effects from administration of these vaccines; 4-year-old patient received PROQUAD and VARIVAX concomitantly; This spontaneous report has been received from a medical assistant referring a 4-years-old patient of unknown gender. The patient's pertinent medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medication were not reported. On 03-AUG-2022, the patient received a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) subcutaneous injection, at the dose of 0.5 milliliters (ml), once for prophylaxis, (lot number U031561 had been verified to be a valid number, expiration date was reported and established as 06-APR-2023) (strength, route of administration and anatomical location were not provided). And with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, at the dose of 0.5 ml for prophylaxis, (lot number U015687 had been verified to be a valid number, expiration date was reported and establised as 18-MAY-2023) (strength, route of administration and anatomical location were not provided) (drug use for unapproved schedule). Both reconstituted with sterile diluent solution for injection, at a dose of 0.7 ml (lot number T020662 had been verified to be a valid number, expiration date was reported and established as 30-DEC-2022). Patient had no symptoms or adverse effects from administration of these vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2403735

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031561

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
06.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No Additonasl AE's a; improperly stored dose of PROQUAD was administered to a patient.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 01-AUG-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) rHA, lot #U031561, expiration date: 06-APR-2023 (strength, exact dose and route of administration were not provided) for prophylaxis (Product storage error). No details regarding the storage conditions were provided. No adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2363697

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U031561

gering
Staat
IL
Alter
11,0
Geschlecht
M
Eingang
09.07.2022
Impfdatum
08.06.2022
Beginn
08.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation error

Symptomtext

No additional AE information provided.; she may have used the MENACTRA as the diluent when administering the PROQUAD; This spontaneous report was received from a registered nurse, referring to an 11-year-old male patient. The patient's medical history and concurrent conditions were not provided. The concomitant medications included meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA). On 08-JUN-2022, the patient was vaccinated with measles, mumps, rubella and varicella (OKA-MERCK) virus vaccine live rHA (PROQUAD) 0.5 mL subcutaneous (SC) (valid lot #U031561, expiration date: 06-APR-2023) as prophylaxis (also reported as Measles, Mumps and Rubella (MMR) and varicella vaccine); however medical assistant was unsure if she accidentally used the a/c/y/w conj (dip tox) (MENACTRA) vaccine as diluent, instead of the sterile diluent (strength, dose, lot #, expiry date, anatomical location were route of administration were not provided) (Product preparation error). Paracetamol (TYLENOL) was given prophylactically round the clock for 24 hours. On 09-JUN-2022, the patient had an appointment with the healthcare professional, and it was stated that the subject was fine, with no reactions, fever, or nothing (also reported as no issues). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
MENACTRA; STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2314097

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U031561

gering
Staat
IL
Alter
11,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
08.06.2022
Beginn
09.06.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Child may have received two Menactra vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-